Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American Homes 4 Rent Class A (AMH) vs Tenet Healthcare Corporation (THC) Price & Performance

American Homes 4 Rent Class ATrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

American Homes 4 Rent Class A vs Tenet Healthcare Corporation — how do they compare? American Homes 4 Rent Class A trades at $33.92 (market cap $12.28B), while Tenet Healthcare Corporation trades at $260.39 (market cap $20.93B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and American Homes 4 Rent Class A pays a 3.87% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.

AMHTHC
Market Cap
$12.28B$20.93B
Sector
Real EstateHealth
52-Week High
$35.82$262.63
52-Week Low
$27.38$161.37
Enterprise Value
$17.35B$32.01B
Dividend Yield
3.87%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American Homes 4 Rent Class A

AMH (American Homes 4 Rent) trades at $34.63, up 0.23% with strong technical momentum and bullish moving averages. The REIT demonstrates robust fundamentals with consistent revenue growth from $1.5B in 2022 to $1.85B in 2025, net income margin expansion to 25.53%, and three consecutive quarterly EPS beats. Recent Q2 2026 results exceeded FFO estimates, prompting raised full-year guidance. Institutional activity shows mixed positioning while analyst consensus remains positive with a $36.45 price target.

AMH presents a compelling opportunity with strong operational execution in the single-family rental market, though investors face risks from regulatory changes affecting institutional home ownership and elevated debt levels. The stock's current valuation at 27.48 P/E appears reasonable given growth trajectory, but monitoring legislative impacts and interest rate sensitivity remains crucial for sustained performance.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.

Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.

Returns comparison

Trailing returns across standard periods

About American Homes 4 Rent Class A

American Homes 4 Rent is a real estate investment trust primarily focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's largest geographical markets include Dallas, Texas

Read more on AMH

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC